ABBOTT LABORATORIES — Director's Dealing 2012

Dec 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-12-10

Reporting Person: Forrest A. David (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-10	Common shares without par value	M	5700	$52.54	Acquired	40715	Direct
2012-12-10	Common shares without par value	M	6200	$55.56	Acquired	46915	Direct
2012-12-10	Common shares without par value	M	9568	$51.74	Acquired	56483	Direct
2012-12-10	Common shares without par value	M	13867	$46.60	Acquired	70350	Direct
2012-12-10	Common shares without par value	S	47286	$65.10	Disposed	23064	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-10	Option (right to buy)	$52.54	M	5700	Acquired	2017-02-15	Common shares (5700)	Direct
2012-12-10	Option (right to buy)	$55.56	M	6200	Acquired	2018-02-14	Common shares (6200)	Direct
2012-12-10	Option (right to buy)	$51.74	M	9568	Acquired	2020-09-16	Common shares (9568)	Direct
2012-12-10	Option (right to buy)	$46.60	M	13867	Acquired	2021-02-17	Common shares (13867)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.